Multi-drug Resistant Tuberculosis: Clinical Trials

3 trials for Multi-drug Resistant Tuberculosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown, 1 withdrawn. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Unknown 1, Withdrawn 1
Phase 22Completed 1, Unknown 1

Follow Multi-drug Resistant Tuberculosis: new trials by email Literature Review of Multi-drug Resistant Tuberculosis trials Research Report on Multi-drug Resistant Tuberculosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Economic Evaluation of New MDR TB Regimens
Bedaquiline, Pretomanid, Moxifloxacin - Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis
Phase 2 / Phase 3CompletedMedecins Sans Frontieres, Netherlands732020-10-202024-04-22
PRACTECAL-PKPD Sub Study
Bedaquiline, Pretomanid, Moxifloxacin - Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis
Phase 2 / Phase 3UnknownMedecins Sans Frontieres, Netherlands2402019-08-062021-05-14
A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis
Arm A Double-blind Phase: TMC207, Arm B Double-blind Phase: Placebo, Treatment Failure During Double-blind Phase: TMC207 - Multi-drug Resistant Tuberculosis
Phase 3WithdrawnJanssen Infectious Diseases BVBA2014-03-012015-12-02

Narrower conditions

Tuberculosis, Multidrug-Resistant (3)  ·  Extensively Drug-Resistant Tuberculosis (2)  ·  Tuberculosis, Pulmonary (2)

Broader conditions

Actinomycetales Infections (3)  ·  Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Gram-Positive Bacterial Infections (3)  ·  Infections (3)  ·  Mycobacterium Infections (3)  ·  Tuberculosis (3)  ·  Lung Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)

Interventions

Clofazimine (2)  ·  Linezolid (2)  ·  Moxifloxacin (2)  ·  bedaquiline (2)  ·  pretomanid (2)

Sponsors

Medecins Sans Frontieres, Netherlands (2)  ·  Janssen Infectious Diseases BVBA (1)

Countries

South Africa (3)  ·  Belarus (2)  ·  Brazil (1)  ·  Cambodia (1)  ·  China (1)  ·  Estonia (1)  ·  Ethiopia (1)  ·  Georgia (1)  ·  Latvia (1)  ·  Mexico (1)  ·  Peru (1)  ·  Philippines (1)  ·  Russia (1)  ·  South Korea (1)  ·  Taiwan (1)

Top investigators

Bern Nyang'wa, MB BS, MPH (1)  ·  Sedona Sweeny (1)

Results publications

PMID 34489274, PMID 41917253, PMID 42270675